Supramolecular peptide vaccines: tuning adaptive immunity.

Journal Article (Review;Journal Article)

Successful immunotherapies must be designed to elicit targeted immune responses having a specifiable phenotype across many dimensions, including the phenotypes of T cells, B cells, antigen-presenting cells, and others. For synthetic or subunit vaccines, stimulation of strong enough immune responses usually requires adjuvants, which can cause local inflammation and complicate the targeting of such phenotypes. Supramolecular materials provide routes for reducing or eliminating supplemental adjuvants. Owing to their compositional controllability, supramolecular assemblies show promise for fine-tuning immune responses by adjusting combinations of material attributes including epitope content, multivalency, size, dose, and small quantities of specific adjuvants. Here we focus on supramolecular vaccines incorporating multiple epitopes in precise ratios, with an emphasis on peptides that form high-aspect ratio (i.e. fibrillar) structures.

Full Text

Duke Authors

Cited Authors

  • Wen, Y; Collier, JH

Published Date

  • August 2015

Published In

Volume / Issue

  • 35 /

Start / End Page

  • 73 - 79

PubMed ID

  • 26163376

Pubmed Central ID

  • PMC4610357

Electronic International Standard Serial Number (EISSN)

  • 1879-0372

International Standard Serial Number (ISSN)

  • 0952-7915

Digital Object Identifier (DOI)

  • 10.1016/j.coi.2015.06.007


  • eng